ImmunoGen Reports Recent Progress and First Quarter 2022 Financial Results

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/24/2026

1. DECK
2. RNG
3. WDC
4. BYD
5. SPOT
6. WCN
7. BMY
8. TSCO
9. BE
10. SPY

Go back to ImmunoGen Reports Recent Progress and First Quarter 2022 Financial Results

Immunogen (IMGN) Tops Q1 EPS by 11c

May 6, 2022 6:32 AM EDT

Immunogen (NASDAQ: IMGN) reported Q1 EPS of ($0.10), $0.11 better than the analyst estimate of ($0.21). Revenue for the quarter came in at $38.1 million versus the consensus estimate of $21.47 million.

GUIDANCE:

Immunogen sees FY2022 revenue of $75-85 million, versus the consensus of $85... More